Bayer (United Kingdom)

Recent papers from Bayer (United Kingdom)

1. GenePHIT Phase 2 baseline characteristics: a double blind, placebo-controlled trial to assess safety and efficacy of AB-1002 gene therapy in heart failure with reduced ejection fractionEuropean Heart Journal · 2026
2. Finerenone in Patients With a Recent Worsening Heart Failure EventJournal of the American College of Cardiology · 2024
3. Cardiac AAV gene therapy: Translational lessons from intracoronary cardiomyocyte-targeted deliveryMolecular Therapy — Nucleic Acids · 2026
4. HFpEF-ABA Score and Finerenone in Patients With Heart Failure and Mildly Reduced or Preserved Ejection FractionENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2026
5. The HFpEF-ABA Score, Incident Heart Failure, and Finerenone in Chronic Kidney Disease with Type 2 DiabetesJournal of Cardiac Failure · 2026
6. Author Correction: Sustainability in medical retina: the environmental impact of using aflibercept 8 mg instead of aflibercept 2 mg in treatment-naïve patients with nAMDEye · 2026
7. An automated quantitative report for multiple sclerosis using only 3D T2-fluid-attenuated inversion recovery MRINeuroradiology · 2026
8. Finerenone in Persons with Chronic Kidney Disease without DiabetesNew England Journal of Medicine · 2026
9. Optimising the patient pathway for macular conditions requiring intravitreal injectionsBMJ Open Ophthalmology · 2026
10. Efficacy and safety of larotrectinib in patients with non-primary central nervous system TRK fusion cancer: An updated analysis.Journal of Clinical Oncology · 2026
11. Efficacy and safety of larotrectinib in patients with TRK fusion lung cancer: An updated analysis.Journal of Clinical Oncology · 2026
12. Cardiovascular-Kidney-Metabolic Overlap in Heart Failure With Mildly Reduced or Preserved Ejection FractionJournal of the American College of Cardiology · 2024
13. Optimizing cohort criteria for multi-country analysis of women experiencing menopause in administrative databasesBMC Medical Research Methodology · 2026
14. Brain Age Estimation on T2 ‐ FLAIR Scans for Application to Multiple SclerosisHuman Brain Mapping · 2026
15. A Review of the Challenge of Pre-Existing Humoral Immunity in Adeno-Associated Virus Gene Therapy and Potential SolutionsHuman Gene Therapy · 2026
16. Finerenone and Quality of Life in Heart Failure: Component-Level Analyses and Clinical Relevance of the Kansas City Cardiomyopathy Questionnaire.2026
17. 209P Efficacy and safety of larotrectinib as first-line treatment for patients with TRK fusion cancerESMO rare cancers. · 2026
18. Finerenone in Type 1 Diabetes and Chronic Kidney DiseaseNew England Journal of Medicine · 2026
19. Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITYJournal of Diabetes and its Complications · 2026
20. Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panelEye · 2026